Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Oxidative Amination. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN107522763B reveals a high-yield route for Sofosbuvir intermediate VII, eliminating chromatography and reducing costs for pharmaceutical manufacturers.
Novel synthesis route for 3 6-diazabicyclo octane derivatives improves solubility and offers cost reduction in API manufacturing for global supply chains.
Discover the metal-free synthesis of aromatic amines via patent CN109134267A. Achieve high purity and cost reduction in pharmaceutical intermediate manufacturing with scalable routes.
Patent CN108912043B reveals a green synthesis method for 2,3,5-trichloropyridine, offering high yields and reduced waste for reliable agrochemical intermediate supply chains.
Patent CN105001169A reveals a copper-catalyzed route for high-purity 3-aminoquinoxaline-2(1H)-one. Discover cost-effective manufacturing and scalable supply chain solutions.
Novel oxidative coupling route for NSC128981 reduces toxic reagents. Enhances supply chain reliability for pharmaceutical intermediates manufacturing with high purity standards.
Novel four-step synthesis of PARP1 inhibitor intermediate via nitration and oxidative deamination. Offers high purity and scalable route for pharmaceutical manufacturing.
Patent CN114853797B reveals a mild selenium-catalyzed method for alpha-amino boron compounds, offering cost reduction and supply chain reliability for pharmaceutical intermediate manufacturing.
Patent CN112574112B details a green oxidative synthesis for N-substituted 2H-indazoles. Discover cost-effective manufacturing and scalable supply chain solutions.
Patent CN114085158A discloses a one-step room temperature synthesis for 4,4'-diaminodiphenyl ether. This method offers significant cost reduction and high purity for polyimide manufacturing.
Patent CN112047925B details a copper-catalyzed oxidative amination route for N-(aryl/heteroaryl) alkyl-diamides, offering significant cost reduction in API manufacturing and scalable supply chain solutions.
Novel palladium-catalyzed route for alpha-amino acid esters using alkenyl ethers. Offers mild conditions and high atom economy for pharmaceutical intermediate manufacturing.